Project

A 52-week, multicenter, randomized, double-blind, placebocontrolled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma

Automatically Closed · 2016 until 2018

Baty Florent, Schlotter Sandra, Brutsche Martin